Stocks and Investing
Stocks and Investing
Mon, November 23, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, November 22, 2015
[ 12:00 AM ] - WOPRAI
Fri, November 20, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, November 19, 2015
[ 12:00 AM ] - WOPRAI
Wed, November 18, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Salveen Richter Initiated (BLUE) at Strong Buy and Held Target at $165 on, Nov 18th, 2015
Salveen Richter of Goldman Sachs, Initiated "bluebird bio, Inc." (BLUE) at Strong Buy and Held Target at $165 on, Nov 18th, 2015.
Salveen has made no other calls on BLUE in the last 4 months.
There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 0 agree with Salveen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Salveen
- Biren Amin of "Jefferies" Initiated at Strong Buy and Held Target at $108 on, Friday, October 23rd, 2015
- Mark Breidenbach of "Oppenheimer" Initiated at Buy and Held Target at $162 on, Tuesday, October 20th, 2015
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $143 on, Monday, October 5th, 2015